# Annual AATD Patient & Family Conference

**Document Version**: 1.0
**Last Updated**: November 8, 2025
**Owner**: Chief Community Engagement Officer
**Purpose**: Host annual multi-day conference bringing together AATD patients, families, researchers, clinicians, and advocates for education, networking, hope, and community building

---

## üìã Table of Contents

1. [Conference Overview](#conference-overview)
2. [Why an Annual Conference Matters](#why-an-annual-conference-matters)
3. [Conference Components](#conference-components)
4. [Educational Sessions](#educational-sessions)
5. [Networking & Community](#networking--community)
6. [Research Symposium](#research-symposium)
7. [Logistics & Planning](#logistics--planning)
8. [Success Metrics](#success-metrics)

---

## Conference Overview

### What We Offer

**Mark Egly Foundation Annual AATD Conference** is a 3-day event bringing the AATD community together:

**Event Details**:

- üìÖ **When**: One weekend in June (Friday-Sunday‚Äîavoid work conflicts)
- üìç **Where**: Rotate cities (Year 1: Denver, Year 2: Cleveland, Year 3: Boston‚Äîmajor AATD centers)
- üéüÔ∏è **Attendees**: 500+ participants (patients, families, doctors, researchers, advocates, industry)
- üíµ **Cost**: FREE for patients & families (Foundation covers registration, meals, conference materials)

**Conference Components**:

- ‚úÖ **Educational Sessions** (30+ sessions‚Äîtreatment updates, lifestyle, coping, research breakthroughs)
- ‚úÖ **Keynote Speakers** (leading AATD researchers, patient advocates, inspirational speakers)
- ‚úÖ **Research Symposium** (scientists present latest findings‚Äîgene therapy, biomarkers, clinical trials)
- ‚úÖ **Support Groups** (peer-to-peer sessions‚Äînewly diagnosed, caregivers, lung transplant survivors)
- ‚úÖ **Networking** (meet other patients, connect with specialists, build friendships)
- ‚úÖ **Resource Fair** (50+ exhibitors‚Äîpharmaceutical companies, medical device vendors, patient orgs, Foundation programs)
- ‚úÖ **Family Activities** (kids' programs, teen track, caregiver wellness)
- ‚úÖ **Awards Ceremony** (recognize patient advocates, outstanding researchers, community champions)

**Who Attends**:

- **Patients**: 300+ AATD patients (all ages, all stages‚Äînewly diagnosed to post-transplant)
- **Families**: 150+ family members (spouses, parents, children, caregivers)
- **Clinicians**: 30+ doctors, nurses, genetic counselors (pulmonologists, hepatologists, transplant surgeons)
- **Researchers**: 20+ scientists (present studies, recruit for trials, network)
- **Advocates**: 30+ patient advocates, policymakers, nonprofit leaders
- **Industry**: 20+ pharmaceutical reps, medical device companies (sponsors, exhibitors)

---

### Conference Goals

**Year 1** (2026):

- 500 attendees (Denver, CO)
- 30 educational sessions
- 10 keynote speakers
- 50 exhibitors
- $200K budget (Foundation-funded)

**Year 3** (2028):

- 1,500 attendees (rotate cities)
- 75 educational sessions
- Livestream sessions (10K+ virtual attendees‚Äîcan't travel)
- $750K budget (corporate sponsors cover 50%)

**Year 5** (2030):

- 3,000 in-person attendees + 50K virtual
- Premier AATD event (like Michael J. Fox Foundation Parkinson's conference, CF Foundation conference)
- International attendees (Europe, Asia‚ÄîAATD is global)
- $2M budget (fully sponsored by pharma, industry)

---

## Why an Annual Conference Matters

### Isolation & Need for Community

**Statistics**:

- **AATD is rare** (1 in 2,500) ‚Üí most patients never meet another AATD patient
- **70% of AATD patients** report feeling isolated ("No one understands what I'm going through")
- **50% of AATD patients** have no local support group (rural areas, small towns)

**Consequences**:

- ‚ùå **Depression, anxiety** (higher rates in AATD patients‚Äîchronic illness + isolation)
- ‚ùå **Poor adherence** (patients skip treatments‚Äîno peer support, accountability)
- ‚ùå **Lack of knowledge** (patients don't learn about new treatments, resources‚Äîno information hub)
- ‚ùå **Missed opportunities** (don't connect with clinical trials, specialists, programs that could help)

---

### Power of Community

**Research**:

- **Patients who attend conferences** have better outcomes (studies show higher treatment adherence, better mental health, longer survival)
- **Face-to-face connections** > online groups (deeper relationships, stronger support networks)
- **Peer learning** is powerful (patients learn more from other patients than from doctors‚Äîpractical tips, lived experience)

**Examples from Other Diseases**:

**Michael J. Fox Foundation Parkinson's Conference**:

- Annual event, 1,000+ attendees
- **Impact**: Patients report feeling "less alone", "more hopeful", "better informed about treatments"
- **Research Benefit**: 200+ patients enrolled in clinical trials (at conference‚Äîresearchers recruit directly)

**CF Foundation North American CF Conference**:

- 4,000+ attendees (patients, families, clinicians, researchers)
- **Impact**: CF survival improved (conferences disseminate best practices‚Äîdoctors learn from each other, patients learn about new treatments)

**AATD Can Have the Same**‚Äîbut currently no major annual conference (gap we're filling).

---

### Current AATD Conferences (Limited)

**What Exists Today**:

- **AlphaNet Educational Symposia**: Small regional events (50-100 attendees, 1 day), excellent but limited reach
- **Alpha-1 Foundation National Education Conference**: Held sporadically (not annual, inconsistent), last one 2019 (pre-COVID‚Äînone since)
- **ATS, ERS conferences**: Medical conferences (for researchers, doctors‚Äînot patient-focused, expensive, technical)

**What's Missing**:

- ‚ùå No large-scale annual patient conference (1,000+ attendees)
- ‚ùå No multi-day format (3 days allows deeper learning, stronger networking)
- ‚ùå No free attendance (financial barrier for many patients)
- ‚ùå No family programming (kids, caregivers excluded)

**Mark Egly Foundation Conference Will Be Superior**:

- ‚úÖ **Annual** (every June‚Äîpredictable, tradition)
- ‚úÖ **Large-scale** (500 Year 1, 3,000 Year 5)
- ‚úÖ **Multi-day** (3 days‚Äîtime to learn, connect, recharge)
- ‚úÖ **Free for patients** (Foundation covers registration, meals, conference bag)
- ‚úÖ **Family-friendly** (kids' programs, teen track, caregiver sessions)

---

### Patient Stories

**Story 1: Newly Diagnosed Patient (Feeling Alone)**:

- 45-year-old male, diagnosed ZZ AATD (6 months ago)
- Lives in rural Montana (never met another AATD patient, no local support group)
- Feels isolated, scared, doesn't know what to expect
- **Attends Conference**: Meets 500 other AATD patients, hears inspirational stories (people living full lives with AATD), learns about treatments, connects with specialist
- **Outcome**: "I finally don't feel alone. I met people who understand. I'm hopeful for the first time since my diagnosis."

**Story 2: Caregiver Burnout**:

- Wife of AATD patient (husband on oxygen, needs transplant)
- Exhausted, stressed, no support system (all energy goes to caregiving)
- **Attends Conference**: Attends caregiver sessions (learns coping strategies, self-care), meets other caregivers (shares experiences, validates her feelings), gets respite (kids' program watches her children‚Äîshe gets 2 hours to herself)
- **Outcome**: "I realized I'm not alone. Other caregivers understand. I learned tools to manage stress and take care of myself."

**Story 3: Research Enrollment**:

- 50-year-old female, ZZ AATD, eligible for gene therapy trial
- Didn't know about trial (never heard of gene therapy for AATD)
- **Attends Conference**: Researcher presents gene therapy study, explains trial, recruits participants at conference booth
- **Outcome**: Patient enrolls in trial (receives gene therapy‚Äîpotentially curative), now on path to better health

---

## Conference Components

### Friday (Day 1): Welcome & Foundation

**Morning**:

- **9:00 AM - Registration Opens** (pick up conference badge, program, tote bag)
- **10:00 AM - Welcome Reception** (coffee, pastries, networking)
- **11:00 AM - Opening Ceremony** (Foundation CEO welcome, land acknowledgment, moment of silence for AATD patients we've lost)

**Afternoon**:

- **12:00 PM - Keynote Address** (inspirational speaker‚Äîpatient advocate, celebrity with chronic illness, or leading researcher)
  - Example: "Living Fully with AATD: A Patient's Journey from Diagnosis to Lung Transplant to Thrive"
- **1:00 PM - Lunch** (provided‚Äînetworking, exhibitor hall opens)
- **2:00 PM - Breakout Sessions (Track 1)**:
  - "AATD 101: Newly Diagnosed Track" (for patients diagnosed < 2 years)
  - "Advanced AATD Management" (for long-term patients)
  - "Caregiver Essentials" (for family members)

**Evening**:

- **5:00 PM - Support Group Circles** (small groups‚Äî10-15 people, peer-led)
  - Newly Diagnosed, Lung Transplant Survivors, Liver Disease, Caregivers, Young Adults with AATD, Parents of Kids with AATD
- **7:00 PM - Welcome Dinner** (buffet, entertainment, silent auction fundraiser)

---

### Saturday (Day 2): Education & Research

**Morning**:

- **8:00 AM - Breakfast** (continental‚Äînetworking)
- **9:00 AM - Keynote: State of AATD Research** (leading researcher presents breakthroughs‚Äîgene therapy, biomarkers, clinical trials)
- **10:00 AM - Breakout Sessions (Track 2)**: 15 concurrent sessions (choose based on interest)
  - **Treatment**: "Augmentation Therapy: What You Need to Know", "Oxygen Therapy Tips", "Preparing for Lung Transplant"
  - **Lifestyle**: "Exercise & Pulmonary Rehab", "Nutrition for AATD", "Mental Health & Chronic Illness"
  - **Research**: "Gene Therapy Trials", "Inhaled AAT", "Biomarkers for Disease Progression"
  - **Advocacy**: "How to Advocate for Newborn Screening", "Grassroots Organizing", "Sharing Your Story with Media"
  - **Family**: "AATD Genetics for Families", "Talking to Kids About AATD", "Career Counseling for AATD Patients"

**Afternoon**:

- **12:00 PM - Lunch** (boxed lunches, exhibitor hall, one-on-one consultations with specialists)
- **1:00 PM - Research Symposium** (scientists present studies‚Äî10-minute talks, Q&A)
  - "Natural History of AATD" (FEV1 decline rates)
  - "Real-World Outcomes with Augmentation Therapy" (registry data)
  - "Gene Therapy: Phase 2 Results" (efficacy, safety)
  - "Inhaled AAT: Proof of Concept" (easier than IV)
  - "Liver Disease in AATD: Screening & Management"
- **3:00 PM - Ask the Experts Panel** (5 AATD specialists answer audience questions‚Äîlive Q&A)

**Evening**:

- **5:00 PM - Free Time** (explore city, rest, informal networking)
- **7:00 PM - Awards Dinner** (recognize outstanding contributions):
  - **Patient Advocate of the Year** (AATD patient who made impact‚Äîpolicy, awareness, fundraising)
  - **Outstanding Researcher** (scientist advancing AATD knowledge)
  - **Healthcare Hero** (doctor, nurse, or provider delivering exceptional AATD care)
  - **Community Champion** (volunteer, donor, or partner supporting Foundation)

---

### Sunday (Day 3): Empowerment & Action

**Morning**:

- **8:00 AM - Breakfast** (continental)
- **9:00 AM - Keynote: Patient Empowerment** (how to take control of your health, advocate for yourself, live fully with AATD)
- **10:00 AM - Breakout Sessions (Track 3)**: Action-oriented workshops
  - "Building Your AATD Care Team" (find specialist, coordinate care)
  - "Navigating Insurance Appeals" (fight denials, maximize coverage)
  - "Clinical Trials: Should You Participate?" (how to decide, find trials, enroll)
  - "Starting a Local AATD Chapter" (grassroots organizing toolkit)
  - "Financial Assistance Resources" (Foundation programs, copay assistance, emergency funds)

**Afternoon**:

- **12:00 PM - Lunch** (provided‚Äîfinal networking)
- **1:00 PM - Closing Ceremony** (recap highlights, thank sponsors, announce next year's conference location, group photo)
- **2:00 PM - Conference Ends**

---

## Educational Sessions

### Session Categories (30+ Sessions Total)

**Track 1: Newly Diagnosed** (For patients diagnosed < 2 years):

1. AATD 101: What is Alpha-1?
2. Understanding Your Test Results
3. Treatment Options: Augmentation Therapy, Inhalers, Oxygen
4. Finding Your AATD Specialist
5. Navigating Insurance (Prior Authorization, Appeals, Copay Assistance)

**Track 2: Disease Management** (For all patients): 6. Living Well with AATD: Exercise, Diet, Lifestyle 7. Managing Exacerbations (Warning Signs, Action Plans) 8. Oxygen Therapy: Tips & Tricks 9. Pulmonary Rehabilitation: Why It Works 10. Mental Health & AATD (Coping with Chronic Illness) 11. Sleep Apnea & AATD (Common comorbidity) 12. Vaccinations & AATD (Flu, Pneumonia, COVID)

**Track 3: Advanced Disease** (For severe AATD): 13. Preparing for Lung Transplant 14. Life After Transplant (Immunosuppression, Rejection, Recovery) 15. Palliative Care & End-of-Life Planning

**Track 4: Liver Disease**: 16. AATD Liver Disease: Screening & Management 17. Pediatric AATD & Liver Disease 18. Liver Transplant: When & Why

**Track 5: Research & Clinical Trials**: 19. Gene Therapy for AATD: The Future is Now 20. Inhaled AAT: Easier Than IV? 21. Biomarkers: Predicting Disease Progression 22. Clinical Trials: How to Find & Enroll 23. Patient Registries: Why Your Data Matters

**Track 6: Family & Genetics**: 24. AATD Genetics for Families 25. Cascade Testing: Getting Your Family Tested 26. AATD in Children (Symptoms, Diagnosis, Management) 27. Pregnancy & AATD (Risks, PGD, Prenatal Testing) 28. Carrier Status (SZ, MZ‚ÄîWhat It Means)

**Track 7: Advocacy & Policy**: 29. Advocacy 101: How to Make an Impact 30. Newborn Screening for AATD (State Legislation) 31. Legislative Advocacy: Talking to Policymakers 32. Media Training for AATD Advocates

**Track 8: Caregivers & Family**: 33. Caregiving for AATD Patients (Practical Tips) 34. Caregiver Self-Care (Avoiding Burnout) 35. Talking to Kids About AATD (Age-Appropriate Explanations) 36. Supporting Your Loved One (Emotional, Medical, Lifestyle)

**Track 9: Special Populations**: 37. Young Adults with AATD (Career, Relationships, Planning) 38. AATD in Seniors (Aging with AATD) 39. Veterans with AATD (VA Benefits, Military Exposures) 40. Women's Health & AATD (Pregnancy, Menopause, Osteoporosis)

---

### Speaker Types

**Clinicians** (Pulmonologists, Hepatologists, Genetic Counselors):

- Present medical topics (treatment, diagnosis, management)
- Answer patient questions (Q&A sessions)

**Researchers** (Scientists Studying AATD):

- Present latest research (gene therapy, biomarkers, clinical trials)
- Recruit for trials (conference = ideal recruitment venue)

**Patients** (AATD Patients Sharing Their Stories):

- Inspirational talks ("How I Thrived After Transplant")
- Practical tips ("My Top 10 AATD Life Hacks")
- Advocacy ("How I Got Newborn Screening Passed in My State")

**Foundation Staff** (Patient Navigators, Genetic Counselors):

- Teach practical skills (insurance appeals, finding specialists, financial assistance)

**Industry** (Pharma Reps, Device Companies):

- Product demonstrations (oxygen concentrators, nebulizers, augmentation therapy brands)
- Copay assistance programs (how to enroll)

---

## Networking & Community

### Structured Networking

**Buddy Program**:

- First-time attendees matched with "conference buddy" (veteran attendee‚Äîshows them around, introduces to people)

**Meet & Greets**:

- By genotype (ZZ patients, SZ patients, rare variants)
- By location (state-specific gatherings‚Äî"Texas AATD Patients Meetup")
- By stage (newly diagnosed, on oxygen, post-transplant)

**Roundtables**:

- Small group discussions (10-12 people, moderated by facilitator)
- Topics: "Coping with Diagnosis", "Work/Life Balance with AATD", "Relationships & AATD", "Parenting with AATD"

---

### Support Groups

**Peer-Led Circles** (Friday Evening, 90 Minutes):

- Newly Diagnosed (20-30 people‚Äîshare fears, ask questions, hear veteran patients' advice)
- Lung Transplant Survivors (share experiences, recovery tips, emotional support)
- Liver Disease (patients with AATD liver disease‚Äîrare, benefit from connecting with others)
- Caregivers (spouses, parents‚Äîshare caregiving challenges, self-care strategies)
- Young Adults with AATD (ages 18-35‚Äîcareer, relationships, future planning)
- Parents of Kids with AATD (pediatric patients' parents‚Äîschool accommodations, treatment decisions)

---

### Social Events

**Welcome Dinner** (Friday Night):

- Buffet, music, silent auction (fundraiser‚Äî100% of proceeds to Foundation programs)
- Icebreaker activities (name tag stickers‚Äî"Ask me about my transplant", "Newly diagnosed", "Gene therapy hopeful")

**Awards Dinner** (Saturday Night):

- Formal recognition (Patient Advocate, Researcher, Healthcare Hero, Community Champion)
- Keynote speech (inspirational‚Äîpatient who overcame odds, advocate who changed policy)
- Entertainment (live music, comedian, magician)

**Exhibitor Hall**:

- Open during lunch, breaks
- 50+ booths (pharmaceutical companies, medical device vendors, Foundation programs, patient orgs, research studies)
- Free swag (pens, tote bags, stress balls), product demos, prize drawings

---

## Research Symposium

### Goal: Accelerate AATD Research

**Format**:

- 10-minute presentations (researchers present studies‚Äîconcise, accessible to patients)
- Q&A (audience asks questions‚Äîresearchers explain findings)
- Poster session (50+ posters‚Äîresearchers display studies, discuss with attendees)

---

### Topics (10-15 Presentations)

**Basic Science**:

- "Z Protein Misfolding: New Therapeutic Targets"
- "CRISPR for AATD: Preclinical Results"

**Clinical Research**:

- "Natural History of AATD: 10-Year Registry Data"
- "Augmentation Therapy: Real-World Effectiveness"
- "Lung Transplant Outcomes in AATD"

**Translational Research**:

- "Gene Therapy Phase 2 Results: Efficacy & Safety"
- "Inhaled AAT: Proof of Concept Study"
- "Biomarkers for Rapid Disease Progression"

**Health Services Research**:

- "Disparities in AATD Care: Rural vs. Urban"
- "Cost-Effectiveness of Augmentation Therapy"

**Quality of Life**:

- "Mental Health Interventions for AATD Patients"
- "Pulmonary Rehab: Impact on QOL"

---

### Benefits for Researchers

**Networking**: Meet other AATD researchers (collaborate, share data, apply for grants together)

**Recruitment**: Recruit patients for clinical trials (500 patients in one place‚Äîefficient, cost-effective)

**Feedback**: Get patient input (what research questions matter to patients? what outcomes should trials measure?)

**Funding**: Connect with pharma (potential sponsors for research projects)

---

## Logistics & Planning

### Venue Selection

**Year 1: Denver, CO** (National Jewish Health‚Äîpremier AATD center):

- **Hotel**: Sheraton Denver Downtown (500-person capacity, conference rooms, AV equipment)
- **Cost**: $150K (venue rental, AV, catering for 500 attendees √ó 3 days)

**Year 2: Cleveland, OH** (Cleveland Clinic)

**Year 3: Boston, MA** (Mass General, Brigham)

**Criteria**:

- Major city (easy to fly to‚Äîdirect flights)
- Near AATD Center of Excellence (attendees can tour, meet specialists)
- Accessible venue (wheelchair-accessible, oxygen-friendly, quiet rooms for patients on oxygen)

---

### Registration

**Free for Patients & Families** (Foundation covers):

- Registration fee ($200 value)
- Meals (Friday dinner, Saturday breakfast/lunch/dinner, Sunday breakfast/lunch‚Äî$100 value)
- Conference materials (program, tote bag, notepad, pen‚Äî$20 value)

**Paid for Clinicians, Industry** (offset costs):

- Clinicians: $300 (doctors, nurses, genetic counselors)
- Industry: $500 (pharma reps, device companies)
- Researchers: Free (encourage research participation)

**Travel Grants** (For Patients with Financial Need):

- Foundation offers travel grants (up to $500‚Äîcover flight, hotel)
- Apply when registering (income < 200% FPL‚Äîdemonstrate need)

---

### Accessibility

**Medical Accommodations**:

- Oxygen stations (refill portable concentrators)
- Quiet rooms (rest, breathing treatments)
- Wheelchair-accessible (all rooms, elevators, bathrooms)
- Medical staff on-site (nurse, respiratory therapist‚Äîhandle emergencies)

**Dietary**:

- Gluten-free, vegetarian, vegan, allergy-friendly options (all meals)

**Interpretation**:

- Spanish interpretation (for sessions‚Äî20% of attendees may be Hispanic)
- ASL interpreters (for deaf attendees)

**Family-Friendly**:

- Kids' program (ages 5-12‚Äîchildcare during sessions, so parents can attend)
- Teen track (ages 13-17‚Äîseparate sessions on growing up with AATD, college planning, advocacy)

---

### Marketing & Promotion

**Email Campaign**:

- Foundation mailing list (10K patients)
- Send 3 emails: "Save the Date" (3 months prior), "Early Bird Registration" (2 months prior), "Last Chance to Register" (1 month prior)

**Social Media**:

- Facebook ads (target AATD groups)
- Instagram (patient stories, speaker announcements, countdown posts)
- Twitter (use hashtag #AAT DConf2026)

**Partnerships**:

- AlphaNet, Alpha-1 Foundation (co-promote conference)
- AATD Centers (doctors encourage patients to attend)

**Press**:

- Press release (local media‚ÄîDenver news covers conference, interviews patients)

---

### Budget (Year 1: $200K)

**Venue & Catering** ($150K):

- Hotel rental, AV, meals for 500 attendees √ó 3 days

**Speakers** ($20K):

- Honoraria for keynote speakers ($2K each √ó 3 = $6K)
- Travel reimbursement for clinicians, researchers (flights, hotels‚Äî$14K)

**Travel Grants for Patients** ($20K):

- 40 patients √ó $500 each (help patients afford attendance)

**Marketing** ($5K):

- Social media ads, printing (programs, banners, signage)

**Swag & Materials** ($3K):

- Conference tote bags, programs, name badges, lanyards

**Miscellaneous** ($2K):

- Contingency (unexpected expenses)

**Revenue**:

- Clinician registrations: 30 √ó $300 = $9K
- Industry registrations: 20 √ó $500 = $10K
- Exhibitor booths: 50 √ó $1K = $50K
- Corporate sponsorships: $100K (pharma companies‚ÄîCSL Behring, Takeda, Grifols)
- **Total Revenue**: $169K

**Net Cost to Foundation**: $31K (Foundation fundraises to cover)

---

## Success Metrics

### Track Annually

**Attendance**:

- # of attendees (patients, families, clinicians, researchers, industry)
- % of registered attendees who showed up (goal: 90%+)
- Demographics (age, genotype, geography‚Äîensure diverse attendance)

**Engagement**:

- Session attendance (average # of people per session)
- Exhibitor hall traffic (# of booth visits)
- Social media engagement (#AAT DConf2026 mentions, reach, impressions)

**Patient Satisfaction**:

- Post-conference survey (5-star rating, testimonials, suggestions)
- Net Promoter Score (would you recommend this conference?)
- % who plan to attend next year

**Research Impact**:

- # of patients enrolled in clinical trials (at conference)
- # of research collaborations formed (researchers networking)

**Advocacy Impact**:

- # of attendees who commit to advocacy (sign pledge‚Äî"I will contact my legislator", "I will start a local chapter")

**Fundraising**:

- $ raised from silent auction, corporate sponsorships

---

### Year 1 Targets

**Attendance**:

- 500 attendees (300 patients, 150 families, 30 clinicians, 20 researchers)
- 90% show-up rate

**Satisfaction**:

- 4.5+ average rating (5-star scale)
- 80% would recommend to others
- 70% plan to attend next year

**Impact**:

- 50 patients enrolled in clinical trials
- 100 attendees commit to advocacy

**Fundraising**:

- $50K raised (silent auction, sponsorships)

---

## Summary

**Mark Egly Foundation Annual AATD Conference**:

- ‚úÖ **3-Day Event** (education, networking, research, community)
- ‚úÖ **FREE for Patients** (Foundation covers registration, meals, materials)
- ‚úÖ **30+ Educational Sessions** (treatment, lifestyle, research, advocacy, family)
- ‚úÖ **500+ Attendees** (Year 1‚Äîgrowing to 3,000 Year 5)
- ‚úÖ **Support Groups** (peer-to-peer connections, emotional support)
- ‚úÖ **Research Symposium** (latest findings, clinical trial recruitment)

**This conference will transform the AATD community**:

- **Patients** will feel less alone, more hopeful, better informed ‚Üí live longer, thrive
- **Families** will understand AATD, support loved ones, take care of themselves
- **Researchers** will recruit for trials, collaborate, accelerate cures
- **Advocates** will learn skills, build networks, change policy

**"Together, we are stronger."**

---

**Ready to Attend?**

**Mark Egly Foundation Annual AATD Conference**
üìÖ June 13-15, 2026 | Denver, CO
üìû Phone: 1-800-AATD-CONF
üìß Email: conference@markeglyfoundation.org
üåê Website: MarkEglyFoundation.org/Conference

---

**Approved by**: Board of Directors
**Effective Date**: January 1, 2026
**Review Date**: Annually
**Version**: 1.0

---

_"Community heals."_

**‚Äî Mark Egly Foundation**
